Khiron Life Sciences Corp. 4KH

FWB: 4KH | ISIN: CA49374L3065 8/05/2023

0,022 EUR (-6,09%)

(-6,09%) 8/05/2023

Grafiek Khiron Life Sciences Corp.

Grafiek Khiron Life Sciences Corp.

1 dag1d -6,09%
1 week1w 0,00%
1 maand1m 0,00%
3 maanden3m 0,00%
6 maanden6m 0,00%
1 jaar1j 0,00%
5 jaar5j -99,01%

Khiron Life Sciences Corp. in het nieuws

Toon enkel gratis nieuws

19 januari 2023 · Khiron begins dispensation of insurance-covered prescriptions in Colombia · Persbericht

16 januari 2023 · NHS reimburses the cost of cannabis treatment to the first Zerenia™ Clinics UK patient · Persbericht

9 januari 2023 · Khiron wins first medical cannabis contract with Colombia's largest public insurance company · Persbericht

5 januari 2023 · Government of Colombia Declares Mandatory Insurance Coverage for Medical Cannabis Products · Persbericht

30 november 2022 · Khiron Life Sciences Reports Third Quarter 2022 Financial Results · Persbericht

18 november 2022 · Khiron to Host Third Quarter 2022 Conference Call on November 30, 2022 · Persbericht

16 november 2022 · Khiron begins sales in Switzerland and expands its medical cannabis portfolio in Germany and the United Kingdom · Persbericht

13 september 2022 · Khiron Life Sciences Awarded Best Latin American Cannabis Company at Benzinga Cannabis Capital Conference · Persbericht

1 september 2022 · Khiron, the Global Leader in Medical Cannabis Launches New Cannabis Products in Europe including Stellar Genetics from California · Persbericht

29 augustus 2022 · Khiron Life Sciences Reports Second Quarter 2022 Financial Results · Persbericht

Profiel Khiron Life Sciences Corp.

Farmaceutische producten: Andere

Gezondheidstechnologie

Landbouwgrondstoffen/Maling

Medicinale en botanische productie

Procesindustrieën

Werknemers: 1.955

Aandelen Khiron Life Sciences Corp.

Beurswaarde: 5,02 miljoen EUR

Effecten: 232,41 miljoen

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe